Mechanistic target of rapamycin (mTOR): a potential new therapeutic target for rheumatoid arthritis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Mechanistic target of rapamycin (mTOR): a potential new therapeutic target for rheumatoid arthritis ; volume:25 ; number:1 ; day:2 ; month:10 ; year:2023 ; pages:1-13 ; date:12.2023
Arthritis Research & Therapy ; 25, Heft 1 (2.10.2023), 1-13, 12.2023
- Urheber
-
Zhang, Fen
Cheng, Ting
Zhang, Sheng-Xiao
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-023-03181-w
- URN
-
urn:nbn:de:101:1-2024013114210967553568
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhang, Fen
- Cheng, Ting
- Zhang, Sheng-Xiao
- SpringerLink (Online service)
Ähnliche Objekte (12)
Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
The role of the kinase mechanistic Target Of Rapamycin – mTOR – and the RNA-binding protein Pumilio2 in epileptogenesis
Untersuchungen zur bestrahlungskombinierten Hemmung des mammalian target of rapamycin (mTOR) bei Glioblastomen
Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas
Blocking Mammalian Target of Rapamycin (mTOR) Alleviates Neuropathic Pain Induced by Chemotherapeutic Bortezomib
Effect of Akt (PKB) on the activity of mammalian target of rapamycin (mTOR)
Triggering of Eryptosis, the Suicidal Erythrocyte Death by Mammalian Target of Rapamycin (mTOR) inhibitor Temsirolimus
Pharmacological studies of a novel inhibitor of the mammalian target of rapamycin (mTOR) signaling pathway
Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease
TOR : target of rapamycin ; with 7 tables
The modulation of mechanistic target of rapamycin (mTOR) via proline-rich Akt substrate of 40 kDa (PRAS40) in a model of endothelial inflammation
Inhibition of the mechanistic target of rapamycin induces cell survival via MAPK in tuberous sclerosis complex
Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
The role of the kinase mechanistic Target Of Rapamycin – mTOR – and the RNA-binding protein Pumilio2 in epileptogenesis
Untersuchungen zur bestrahlungskombinierten Hemmung des mammalian target of rapamycin (mTOR) bei Glioblastomen
Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas
Blocking Mammalian Target of Rapamycin (mTOR) Alleviates Neuropathic Pain Induced by Chemotherapeutic Bortezomib
Effect of Akt (PKB) on the activity of mammalian target of rapamycin (mTOR)
Triggering of Eryptosis, the Suicidal Erythrocyte Death by Mammalian Target of Rapamycin (mTOR) inhibitor Temsirolimus
Pharmacological studies of a novel inhibitor of the mammalian target of rapamycin (mTOR) signaling pathway
Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease
TOR : target of rapamycin ; with 7 tables
The modulation of mechanistic target of rapamycin (mTOR) via proline-rich Akt substrate of 40 kDa (PRAS40) in a model of endothelial inflammation
Inhibition of the mechanistic target of rapamycin induces cell survival via MAPK in tuberous sclerosis complex
Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
The role of the kinase mechanistic Target Of Rapamycin – mTOR – and the RNA-binding protein Pumilio2 in epileptogenesis
Untersuchungen zur bestrahlungskombinierten Hemmung des mammalian target of rapamycin (mTOR) bei Glioblastomen
Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas
Blocking Mammalian Target of Rapamycin (mTOR) Alleviates Neuropathic Pain Induced by Chemotherapeutic Bortezomib
Effect of Akt (PKB) on the activity of mammalian target of rapamycin (mTOR)
Triggering of Eryptosis, the Suicidal Erythrocyte Death by Mammalian Target of Rapamycin (mTOR) inhibitor Temsirolimus
Pharmacological studies of a novel inhibitor of the mammalian target of rapamycin (mTOR) signaling pathway
Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease
TOR : target of rapamycin ; with 7 tables
The modulation of mechanistic target of rapamycin (mTOR) via proline-rich Akt substrate of 40 kDa (PRAS40) in a model of endothelial inflammation